Diligent Investors, LLC Cognition Therapeutics Inc Transaction History

Diligent Investors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$1.51 - $2.3 $15,100 - $23,000	-10,000 Reduced 50.0%	10,000 $19,000
Q4 2022 Jan 20, 2023	SELL	$1.17 - $3.51 $12,308 - $36,925	-10,520 Reduced 34.47%	20,000 $0
Q1 2022 Apr 26, 2022	BUY	$2.41 - $6.9 $73,553 - $210,588	30,520 New	30,520 $84,000

9.4M

Ticker CGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,710,700
Market Cap $43.4M
Description
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...

Get notified when there are updates to the investment portfolio of Diligent Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Diligent Investors, LLC with notifications on news.